NCT01601808 2025-03-13
ViP
University of Liverpool
Phase 2 Completed
Clinical Trials
10 trialsNCT01183559 2021-01-22
A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
Fox Chase Cancer Center
Phase 1 Completed
NCT00508001 2016-10-10
Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)
Sanofi
Phase 2 Completed
NCT00753675 2016-10-10
VANGOGH
Sanofi
Phase 2 Completed
NCT00454116 2016-10-07
A Phase II, Double Blind Study of 2 Doses of ZACTIMAâ„¢(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients
Sanofi
Phase 2 Completed
NCT00681798 2016-08-29
Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma
Sanofi
Phase 1 Completed
NCT00496509 2016-08-26
Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer
Sanofi
Phase 1 Completed
NCT00551096 2013-12-25
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
University of Colorado, Denver
Phase 1 Completed
NCT00436072 2012-10-04
ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00532909 2012-07-16
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
Stanford University
Phase 1 Completed